Last reviewed · How we verify

NCT03748381

Comparison of 2 Diffractive Trifocal IOLs

Status unknown NA Last updated 23 November 2018
What this trial tests

NA trial testing Cataract surgery in Cataract in 44 participants. Status unknown.

Timeline
1 April 2018
Primary endpoint
1 April 2020
1 April 2020

Quick facts

Lead sponsorPrim. Prof. Dr. Oliver Findl, MBA
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment44
Start date1 April 2018
Primary completion1 April 2020
Estimated completion1 April 2020
Sites1 location across Austria

Drugs / interventions tested

Conditions studied

Sponsor

Prim. Prof. Dr. Oliver Findl, MBA

Who can join

Adults 21 to 105, any sex, with Cataract. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Compare two commercially available bilateral implanted diffractive trifocal lenses (Zeiss AT Lisa tri vs. Rayner trifocal) after cataract surgery concerning visual function and spectacle independence.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Cataract surgery

Trials testing the same drug.

Other recruiting trials for Cataract

Currently open trials in the same condition.

Other Prim. Prof. Dr. Oliver Findl, MBA trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03748381.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing